"Florida Research Institute is a multi-therapeutic clinical research site and a global leader in gastroenterology and hepatology research. We offer the latest, most advanced treatments to those in need."

During the past decade, Florida Research Institute conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 9 clinical trials were completed, i.e. on average, 28.1% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 9 clinical trials were completed. i.e. 52.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Florida Research Institute" #1 sponsor was "Gilead Sciences" with 5 trials, followed by "Galapagos NV" with 4 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Madrigal Pharmaceuticals, Inc." with 3 trials sponsored and "CymaBay Therapeutics, Inc." with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Research Institute" #1 collaborator was "Gilead Sciences" with 4 trials as a collaborator, "DSM Nutritional Products, Inc." with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Florida Research Institute" are "Crohn's Disease" (5 trials), "NASH - Nonalcoholic Steatohepatitis" (4 trials), "Nonalcoholic Steatohepatitis" (4 trials), "Non-Alcoholic Fatty Liver Disease" (3 trials) and "Nonalcoholic Fatty Liver Disease" (2 trials). Many other conditions were trialed in "Florida Research Institute" in a lesser frequency.

Most popular intervention types in "Florida Research Institute" are "Drug" (31 trials), "Biological" (2 trials), "Other" (2 trials), "Combination Product" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Filgotinib" (5 trials), "Guselkumab" (3 trials), "SEL" (3 trials) and "Golimumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Florida Research Institute" are 31 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Florida Research Institute". undefined are not yet recruiting, 11 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in Florida Research Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Florida Research Institute, 1 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Florida Research Institute has several departments that took part in Clinical trials: "Florida Center for Gastroenterology" - 28 trials, "Florida Digestive Health Specialists" - 9 trials